Hinckley, Ohio-based ClinicalRM is no stranger to government and military biomedical research. As of today, they are $97 million more familiar with such work.
A full-service contract research organization providing expertise in basic and applied research, clinical trials, and regulatory support, ClinicalRM announced today it has been awarded a new, 5-year, $97MM research support contract titled Support for Military Medical Research for the Soldier (SMMRS) to be performed at the Walter Reed Army Institute of Research (WRAIR).
Through the course of the contract, ClinicalRM will provide support for WRAIR’s goal of improving both national and international efforts to develop drugs, vaccines and associated products to address diseases of strategic interest to the military and to develop products to enhance warfighter resilience.
“We are very proud of the support our company currently provides to WRAIR which makes this award especially important. It is a testament to the value we bring to critical research that supports the warfighter and our country,” said Victoria Tifft, founder and CEO of ClinicalRM.
For nearly two decades, ClinicalRM has partnered witht the U.S. Armed Forces on basic and applied research, clinical trials, and regulatory approval for a wide variety of agents. Tifft played a major role in establishing the WRAIR Clinical Trials Center more than 15 years ago.
View ClinicalRM’s press release on their web site.
